Cargando…

Pneumococcal vaccine coverage among individuals aged 18 to 64 years old with underlying medical conditions in the UK: a retrospective database analysis

BACKGROUND: In the UK certain groups with pre-disposing conditions are eligible for vaccination with the pneumococcal polysaccharide vaccine (PPV23). Uptake of the vaccine in these individuals has not been reported for 10 years. Hence this study investigated the rates of pneumococcal vaccination, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matthews, Ian, Lu, Xiaoyan, Xia, Qian, Black, Wynona, Nozad, Bayad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579959/ https://www.ncbi.nlm.nih.gov/pubmed/33087085 http://dx.doi.org/10.1186/s12889-020-09613-5

Ejemplares similares

Burden of disease from shingles and post-herpetic neuralgia in the over 80 year olds in the UK
por: Matthews, Ian, et al.
Publicado: (2020)

Immunogenicity of a 20-valent pneumococcal conjugate vaccine in adults 18 to 64 years old with medical conditions and other factors that increase risk of pneumococcal disease
por: Sabharwal, Charu, et al.
Publicado: (2022)

Pneumococcal vaccination coverage in individuals (16–59 years) with a newly diagnosed risk condition in Germany
por: Deb, Arijita, et al.
Publicado: (2022)

Health Insurance Coverage by Occupation Among Adults Aged 18–64 Years — 17 States, 2013–2014
por: Boal, Winifred L., et al.
Publicado: (2018)

Uptake of 13-Valent Pneumococcal Conjugate Vaccine among US Adults Aged 19 to 64 Years with Immunocompromising Conditions
por: Vietri, Jeffrey, et al.
Publicado: (2019)

Clinical and economic burden of pneumococcal disease in US adults aged 19–64 years with chronic or immunocompromising diseases: an observational database study
por: Zhang, Dongmu, et al.
Publicado: (2018)

1442. Pneumonia Hospitalizations Averted With 13-Valent Pneumococcal Conjugate Vaccination of Adults Aged 18–64 Years With Diabetes in the United States
por: Suaya, Jose, et al.
Publicado: (2018)

107. Identification of state-level variables associated with changes in vaccination coverage rates in adults aged 18 to 64 in the United States
por: Eiden, Amanda, et al.
Publicado: (2022)

Regional factors associated with pneumococcal vaccination coverage among U.S. adults with underlying chronic or immunocompromising conditions
por: Liu, Junqing, et al.
Publicado: (2023)

Influenza vaccine uptake among at-risk adults (aged 16–64 years) in the UK: a retrospective database analysis
por: Oakley, Simon, et al.
Publicado: (2021)

Chronic medical conditions associated with invasive pneumococcal diseases in inpatients in teaching hospitals in São Paulo city: Estimating antimicrobial susceptibility and serotype-coverage of pneumococcal vaccines
por: Kfouri, Renato A., et al.
Publicado: (2023)

The relationship between health literacy with health status and healthcare utilization in 18-64 years old people in Isfahan
por: Karimi, Saeed, et al.
Publicado: (2014)

Influenza vaccine coverage in 6months-64 years-old patients affected by chronic diseases: A retrospective cohort study in Italy
por: Bianchi, Francesco Paolo, et al.
Publicado: (2023)

Association of Pneumococcal Conjugate Vaccine Coverage With Pneumococcal Meningitis: An Analysis of French Administrative Areas, 2001–2016
por: Alari, Anna, et al.
Publicado: (2019)

Evolution, Clinical and Microbiological Characteristics of Invasive Pneumococcal Disease since the Introduction of the Pneumococcal Conjugate Vaccine 13-Valent in Adults over 18 Years Old
por: Buades, Juan, et al.
Publicado: (2021)

Flavonoid Intake in European Adults (18 to 64 Years)
por: Vogiatzoglou, Anna, et al.
Publicado: (2015)

P18 Value of pneumococcal PCR in respiratory samples for exclusion of pneumococcal pneumonia
por: Van Herendael, Bruno, et al.
Publicado: (2023)

Applying an extended protection motivation theory to predict Covid-19 vaccination intentions and uptake in 50–64 year olds in the UK
por: Griffin, Bethany, et al.
Publicado: (2022)

A reflection on invasive pneumococcal disease and pneumococcal conjugate vaccination coverage in children in Southern Europe (2009–2016)
por: Moreira, Marta, et al.
Publicado: (2016)

Pulmonary nodule in an asymptomatic 64-year-old woman.
por: Stern, H., et al.
Publicado: (1986)

Impact of the introduction of pneumococcal conjugate vaccine on immunization coverage among infants
por: Lin, Nancy D, et al.
Publicado: (2005)

Poor Potential Coverage for 7-Valent Pneumococcal Conjugate Vaccine, Malawi
por: Gordon, Stephen B., et al.
Publicado: (2003)

The Impact of Pneumococcal Conjugate Vaccine (PCV) Coverage Heterogeneities on the Changing Epidemiology of Invasive Pneumococcal Disease in Switzerland, 2005–2019
por: Oyewole, Oluwaseun Rume-Abiola, et al.
Publicado: (2021)

Recent Topics of Pneumococcal Vaccination: Indication of Pneumococcal Vaccine for Individuals at a Risk of Pneumococcal Disease in Adults
por: Asai, Nobuhiro, et al.
Publicado: (2021)

COVID-19 vaccine hesitancy January-May 2021 among 18–64 year old US adults by employment and occupation
por: King, Wendy C., et al.
Publicado: (2021)

64-year-old male with septic arthritis of the pubic symphysis
por: Konik, Ewa, et al.
Publicado: (2011)

Database on the coverage of the “Bolsa-Família” conditioning cash-transfer program: Brazil, 2005 to 2021
por: Baroni, Lais, et al.
Publicado: (2021)

Levels of pneumococcal conjugate vaccine coverage and indirect protection against invasive pneumococcal disease and pneumonia hospitalisations in Australia: An observational study
por: Chan, Jocelyn, et al.
Publicado: (2021)

Use of Molecular Imaging Markers of Glycolysis, Hypoxia and Proliferation ((18)F-FDG, (64)Cu-ATSM and (18)F-FLT) in a Dog with Fibrosarcoma: The Importance of Individualized Treatment Planning and Monitoring
por: Zornhagen, Kamilla Westarp, et al.
Publicado: (2015)

Pneumococcal vaccination in children with underlying conditions
por: Principi, Nicola, et al.
Publicado: (2015)

1094 Pneumococcal Vaccination Coverage In The Elderly In The United States: Missed Opportunities Continue
por: Yang, H. Keri, et al.
Publicado: (2014)

An outbreak of Cryptosporidium parvum linked to pasteurised milk from a vending machine in England: a descriptive study, March 2021
por: Gopfert, Anya, et al.
Publicado: (2022)

Pneumococcal vaccination coverages by age, sex and specific underlying risk conditions among middle-aged and older adults in Catalonia, Spain, 2017
por: Vila-Córcoles, Angel, et al.
Publicado: (2019)

Racial and Ethnic Disparities in Insurance Coverage Among US Adults Aged 60 to 64 Years
por: Patterson, Anna, et al.
Publicado: (2022)

Increased Invasive Pneumococcal Disease, North East England, UK
por: Houseman, Catherine, et al.
Publicado: (2017)

Immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine as a booster dose in 12- to 18-month-old children primed with 3 doses of 7-valent pneumococcal conjugate vaccine
por: Thisyakorn, Usa, et al.
Publicado: (2014)

Neuromuscular Blockade and Reversal Agent Practice Variability in the US Inpatient Surgical Settings
por: Bash, Lori D., et al.
Publicado: (2021)

Exploration of 27 plasma immune markers: a cross-sectional comparison of 64 old psychiatric inpatients having unipolar major depression and 18 non-depressed old persons
por: Gaarden, Torfinn Lødøen, et al.
Publicado: (2018)

Measles vaccine coverage and factors related to uncompleted vaccination among 18-month-old and 36-month-old children in Kyoto, Japan
por: Matsumura, Takayo, et al.
Publicado: (2005)

Estimating Haplotype Frequency and Coverage of Databases
por: Egeland, Thore, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_rvhi15i3ctjutvcts9dci0741n